In This Section

Home / Learn / Immunotherapy


Today, with more than 40 cancer immunotherapy indications and over 2,000 clinical trials with cancer immunotherapies, the challenges and issues around patient selection, patient access and side effect management for the community cancer team have grown even more complex. ACCC recognizes and understands these complexities and the rapidly changing IO landscape and strives leading the exchange of solutions to proactively address the operational, optimization, research and educational challenges associated with cancer immunotherapies for the community cancer care team.

Institute for Clinical Immuno-Oncology (ICLIO) 

An ACCC Institute, ICLIO is the only initiative to prepare all members of the multidisciplinary cancer care team for the complex implementation of immuno-oncology in the community setting. ICLIO provides robust resources for staying up to date on this rapidly evolving field, as well as practical real-world information on effectively integrating immunotherapy into practice.

To view all that ICLIO offers and learn about the newest initiatives, visit the ICLIO website at

Learn More

Toxicity Team Article Download

Featured Programs

Elevate Your Immunotherapy Program

“Best Practices for Implementing Cancer Immunotherapy in the Community” is a new ACCC education opportunity that offers two ACCC-member programs customized learning for their multidisciplinary teams delivering immunotherapy for cancer, including an on-site training.
Learn More

Two ACCC member programs are participating in "Overcoming Obstacles in Integrating Immunotherapies for Cancer in the Community Setting," a quality improvement research study. Learn more and view the study design.
Learn More

Real-World Experience in Immunotherapy Delivery

Peer-to-peer learning focused on practical “how to’s” for integrating immunotherapy into practice in the community setting with a focus on physical space considerations, workflow, staffing, patient education, and lessons learned.
Learn More

Managing Immune-Related Adverse Events

The rapid pace of new approvals and indications in immunotherapy for cancer requires ongoing education to understand the spectrum of immune-related adverse events (irAEs) and how to effectively manage your patients’ irAEs using a multidisciplinary approach.
Learn More

From the ACCCBuzz Blog

Upcoming Webinars

View All Webinars

Featured Webinar

CAR T-Cell Therapy for Your Patients: What You Need to Know

CAR-T WebinarWatch Now

On-Demand Webinars

From Oncology Issues

  • Turning on the Light Switch
    By Ann McGreal, RN
    Discover how 2017 ACCC Innovator Award winner Advocate Medical Group developed and implemented an immunotherapy program, lessons learned, and tools created to educate staff and patients.
  •  Best of ASCO 2017
    Cary A. Presant, MD, FACP, FASCO
    ASCO 2017 was filled with new information and long lines as 39,000 oncologists worldwide came together to hear the latest advances in cancer care.
  • Real-World Experiences in Immunotherapy Delivery
    The ACCC education project, “Real-World Experiences in Immunotherapy Delivery,” addresses some of the practical issues that cancer programs must navigate to provide immunotherapy safely and effectively in their own communities.
  • Advancing Immuno-Oncology in the Community Setting
    Steven Powell, MD
    As cancer treatment evolves with the emergence of genomics, personalized therapies, and immunotherapies, care delivery must also transform.

Immunotherapy In the News


SITC - Advances in Cancer Immunotherapy